AbbVie Sponsors New BioLabs Facility in Toronto

Dow Jones
04/21
 

By Christopher Kuo

 

AbbVie is sponsoring BioLabs's new 40,000 square-foot lab and office facility in Toronto.

The biopharmaceutical company said Monday that it has agreed to become the founding sponsor of BioLabs University of Toronto to accelerate life sciences research. The facility will be a fully equipped laboratory and collaboration space for up to 30 early stage biotechnology startups, AbbVie said.

As part of its partnership with BioLabs, AbbVie will also offer an annual innovators award to an early stage biotech recipient, granting them mentorship and a year of laboratory and office space, the company said.

"This new facility will help provide Canadian biotech entrepreneurs with the infrastructure, mentorship and collaborative environment needed to translate promising science into real-world health solutions," said Christian Schubert, vice president and global head of AbbVie.

 

Write to Christopher Kuo at chris.kuo@wsj.com

 

(END) Dow Jones Newswires

 

Christian Schubert is vice president and global head of AbbVie Ventures. "AbbVie Sponsors New BioLabs Facility in Toronto," published at 3:25 p.m. ET on April 20, misstated his title.

 

(END) Dow Jones Newswires

April 21, 2026 12:02 ET (16:02 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10